{"schema_version":"secwatch.filing_event.v1","accession":"0001013762-23-001586","form_type":"8-K","ticker":"EMMA","cik":"0000822370","company_name":"Emmaus Life Sciences, Inc.","filed_at":"2023-10-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.095987+00:00","generated_at":"2026-06-10T05:06:07.690692+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Emmaus appoints George Sekulich to board and Willis Lee as Chairman","bullets":["George Sekulich appointed to fill board vacancy created by Yutaka Niihara's resignation on Sept 25, 2023.","Sekulich also serves as Co-President and Chief Commercial Officer; previously SVP and CIO since July 2019.","Willis Lee, Co-President and COO, appointed as Chairman of the Board of Directors on October 2, 2023.","No family relationships or related-party transactions with Sekulich were disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001013762-23-001586","json":"https://secwatch.observer/filing/0001013762-23-001586.json","markdown":"https://secwatch.observer/filing/0001013762-23-001586.md","text":"https://secwatch.observer/filing/0001013762-23-001586.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/822370/000101376223001586/0001013762-23-001586-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/822370/000101376223001586/ea186291-8k_emmaus.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T05:06:07.690692+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"898ad73013","claim":"Willis Lee was appointed as Chairman of the Board of Directors at Emmaus Life Sciences, Inc..","evidence_excerpt":"Also on October 2, 2023, the Board of Directors appointed Willis Lee, the Co-President and Chief Operating Officer, to serve as Chairman of the Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/822370/000101376223001586/0001013762-23-001586-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chairman of the Board of Directors"}],"fact_type":"executive_change"},{"claim_id":"d7e1396675","claim":"Yutaka Niihara resigned as Director at Emmaus Life Sciences, Inc..","evidence_excerpt":"Yutaka Niihara, M.D., M.P.H., the former Chairman and Chief Executive Officer, resigned as a director effective September 25, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/822370/000101376223001586/0001013762-23-001586-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}